Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Operating Expenses (2013 - 2026)

Updated

Ocular Therapeutix (OCUL) recorded Operating Expenses of $95.58 million in Q2 2026, up 17.9% from $81.1 million a year earlier but down 8.2% from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Operating Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Ocular Therapeutix's Operating Expenses came in at $365.96 million as of Jun 30, 2026, up 28.5% year-over-year; for FY2025, it was $321.97 million, up 36.7% from FY2024.

  • Annual Operating Expenses has increased for five straight years, with a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $235.5 million in FY2024 (+67.2%), $140.83 million in FY2023 (+8.2%), $130.15 million in FY2022 (+7.1%) and $121.56 million in FY2021 (+51.5%).
  • Quarterly Operating Expenses has ranged from $30.36 million in Q4 2021 to $104.13 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for 22 consecutive quarters, with growth averaging 48.1% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Operating Expenses ranged from 0.7% (Q2 2022) to 94.1% (Q4 2024).
  • Per Business Quant, the preceding three quarters came in at $104.13 million (Q1 2026), $83.01 million (Q4 2025) and $83.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 10.12 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.56 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -9.70 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 2.09 Bn
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn 95.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.58 Mn
Mar 31, 2026 104.13 Mn
Dec 31, 2025 83.01 Mn
Sep 30, 2025 83.24 Mn
Jun 30, 2025 81.10 Mn
Mar 31, 2025 74.62 Mn
Dec 31, 2024 67.66 Mn
Sep 30, 2024 61.42 Mn
Jun 30, 2024 60.03 Mn
Mar 31, 2024 46.39 Mn
Dec 31, 2023 34.85 Mn
Sep 30, 2023 34.30 Mn
Jun 30, 2023 35.76 Mn
Mar 31, 2023 35.92 Mn
Dec 31, 2022 33.44 Mn
Sep 30, 2022 33.51 Mn
Jun 30, 2022 32.18 Mn
Mar 31, 2022 31.02 Mn
Dec 31, 2021 30.36 Mn
Sep 30, 2021 31.68 Mn
API Access

Ocular Therapeutix Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=OCUL&period=max&api_key=YOUR_API_KEY